Global Antiparasitic Drugs for Pets Market Growth 2025-2031

Publication ID:

LPI02254047

Publication Date:

February 27, 2025

Pages:

119

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

The global Antiparasitic Drugs for Pets market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.
Antiparasitic Drugs drive away internal and external parasites in pets (such as Toxoplasma gondii, fleas, beer worms, etc.) and are divided into internal anthelmintics and external anthelmintics. Foreign-funded enterprises have a monopoly on Antiparasitic Drugs.
The 鈥淎ntiparasitic Drugs for Pets Industry Forecast鈥� looks at past sales and reviews total world Antiparasitic Drugs for Pets sales in 2024, providing a comprehensive analysis by region and market sector of projected Antiparasitic Drugs for Pets sales for 2025 through 2031. With Antiparasitic Drugs for Pets sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Antiparasitic Drugs for Pets industry.
This Insight Report provides a comprehensive analysis of the global Antiparasitic Drugs for Pets landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Antiparasitic Drugs for Pets portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Antiparasitic Drugs for Pets market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Antiparasitic Drugs for Pets and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Antiparasitic Drugs for Pets.
This report presents a comprehensive overview, market shares, and growth opportunities of Antiparasitic Drugs for Pets market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
In Vitro Deworming Medicine
In Vivo Deworming Medicine
Segmentation by Application:
Cats
Doges
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Zoetis
Boehringer Ingelheim
Merck
Elanco
Virbac
Ceva
Vetoquinol
Ouro Fino Saude
JINDUN
Zhongbolvya
CAHIC
Key Questions Addressed in this Report
What is the 10-year outlook for the global Antiparasitic Drugs for Pets market?
What factors are driving Antiparasitic Drugs for Pets market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Antiparasitic Drugs for Pets market opportunities vary by end market size?
How does Antiparasitic Drugs for Pets break out by Type, by Application?

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Antiparasitic Drugs for Pets Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Antiparasitic Drugs for Pets by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Antiparasitic Drugs for Pets by Country/Region, 2020, 2024 & 2031
2.2 Antiparasitic Drugs for Pets Segment by Type
2.2.1 In Vitro Deworming Medicine
2.2.2 In Vivo Deworming Medicine
2.3 Antiparasitic Drugs for Pets Sales by Type
2.3.1 Global Antiparasitic Drugs for Pets Sales Market Share by Type (2020-2025)
2.3.2 Global Antiparasitic Drugs for Pets Revenue and Market Share by Type (2020-2025)
2.3.3 Global Antiparasitic Drugs for Pets Sale Price by Type (2020-2025)
2.4 Antiparasitic Drugs for Pets Segment by Application
2.4.1 Cats
2.4.2 Doges
2.4.3 Others
2.5 Antiparasitic Drugs for Pets Sales by Application
2.5.1 Global Antiparasitic Drugs for Pets Sale Market Share by Application (2020-2025)
2.5.2 Global Antiparasitic Drugs for Pets Revenue and Market Share by Application (2020-2025)
2.5.3 Global Antiparasitic Drugs for Pets Sale Price by Application (2020-2025)
3 Global by Company
3.1 Global Antiparasitic Drugs for Pets Breakdown Data by Company
3.1.1 Global Antiparasitic Drugs for Pets Annual Sales by Company (2020-2025)
3.1.2 Global Antiparasitic Drugs for Pets Sales Market Share by Company (2020-2025)
3.2 Global Antiparasitic Drugs for Pets Annual Revenue by Company (2020-2025)
3.2.1 Global Antiparasitic Drugs for Pets Revenue by Company (2020-2025)
3.2.2 Global Antiparasitic Drugs for Pets Revenue Market Share by Company (2020-2025)
3.3 Global Antiparasitic Drugs for Pets Sale Price by Company
3.4 Key Manufacturers Antiparasitic Drugs for Pets Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Antiparasitic Drugs for Pets Product Location Distribution
3.4.2 Players Antiparasitic Drugs for Pets Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 World Historic Review for Antiparasitic Drugs for Pets by Geographic Region
4.1 World Historic Antiparasitic Drugs for Pets Market Size by Geographic Region (2020-2025)
4.1.1 Global Antiparasitic Drugs for Pets Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Antiparasitic Drugs for Pets Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Antiparasitic Drugs for Pets Market Size by Country/Region (2020-2025)
4.2.1 Global Antiparasitic Drugs for Pets Annual Sales by Country/Region (2020-2025)
4.2.2 Global Antiparasitic Drugs for Pets Annual Revenue by Country/Region (2020-2025)
4.3 Americas Antiparasitic Drugs for Pets Sales Growth
4.4 APAC Antiparasitic Drugs for Pets Sales Growth
4.5 Europe Antiparasitic Drugs for Pets Sales Growth
4.6 Middle East & Africa Antiparasitic Drugs for Pets Sales Growth
5 Americas
5.1 Americas Antiparasitic Drugs for Pets Sales by Country
5.1.1 Americas Antiparasitic Drugs for Pets Sales by Country (2020-2025)
5.1.2 Americas Antiparasitic Drugs for Pets Revenue by Country (2020-2025)
5.2 Americas Antiparasitic Drugs for Pets Sales by Type (2020-2025)
5.3 Americas Antiparasitic Drugs for Pets Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Antiparasitic Drugs for Pets Sales by Region
6.1.1 APAC Antiparasitic Drugs for Pets Sales by Region (2020-2025)
6.1.2 APAC Antiparasitic Drugs for Pets Revenue by Region (2020-2025)
6.2 APAC Antiparasitic Drugs for Pets Sales by Type (2020-2025)
6.3 APAC Antiparasitic Drugs for Pets Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Antiparasitic Drugs for Pets by Country
7.1.1 Europe Antiparasitic Drugs for Pets Sales by Country (2020-2025)
7.1.2 Europe Antiparasitic Drugs for Pets Revenue by Country (2020-2025)
7.2 Europe Antiparasitic Drugs for Pets Sales by Type (2020-2025)
7.3 Europe Antiparasitic Drugs for Pets Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Antiparasitic Drugs for Pets by Country
8.1.1 Middle East & Africa Antiparasitic Drugs for Pets Sales by Country (2020-2025)
8.1.2 Middle East & Africa Antiparasitic Drugs for Pets Revenue by Country (2020-2025)
8.2 Middle East & Africa Antiparasitic Drugs for Pets Sales by Type (2020-2025)
8.3 Middle East & Africa Antiparasitic Drugs for Pets Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Antiparasitic Drugs for Pets
10.3 Manufacturing Process Analysis of Antiparasitic Drugs for Pets
10.4 Industry Chain Structure of Antiparasitic Drugs for Pets
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Antiparasitic Drugs for Pets Distributors
11.3 Antiparasitic Drugs for Pets Customer
12 World Forecast Review for Antiparasitic Drugs for Pets by Geographic Region
12.1 Global Antiparasitic Drugs for Pets Market Size Forecast by Region
12.1.1 Global Antiparasitic Drugs for Pets Forecast by Region (2026-2031)
12.1.2 Global Antiparasitic Drugs for Pets Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Antiparasitic Drugs for Pets Forecast by Type (2026-2031)
12.7 Global Antiparasitic Drugs for Pets Forecast by Application (2026-2031)
13 Key Players Analysis
13.1 Zoetis
13.1.1 Zoetis Company Information
13.1.2 Zoetis Antiparasitic Drugs for Pets Product Portfolios and Specifications
13.1.3 Zoetis Antiparasitic Drugs for Pets Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Zoetis Main Business Overview
13.1.5 Zoetis Latest Developments
13.2 Boehringer Ingelheim
13.2.1 Boehringer Ingelheim Company Information
13.2.2 Boehringer Ingelheim Antiparasitic Drugs for Pets Product Portfolios and Specifications
13.2.3 Boehringer Ingelheim Antiparasitic Drugs for Pets Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Boehringer Ingelheim Main Business Overview
13.2.5 Boehringer Ingelheim Latest Developments
13.3 Merck
13.3.1 Merck Company Information
13.3.2 Merck Antiparasitic Drugs for Pets Product Portfolios and Specifications
13.3.3 Merck Antiparasitic Drugs for Pets Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Merck Main Business Overview
13.3.5 Merck Latest Developments
13.4 Elanco
13.4.1 Elanco Company Information
13.4.2 Elanco Antiparasitic Drugs for Pets Product Portfolios and Specifications
13.4.3 Elanco Antiparasitic Drugs for Pets Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Elanco Main Business Overview
13.4.5 Elanco Latest Developments
13.5 Virbac
13.5.1 Virbac Company Information
13.5.2 Virbac Antiparasitic Drugs for Pets Product Portfolios and Specifications
13.5.3 Virbac Antiparasitic Drugs for Pets Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Virbac Main Business Overview
13.5.5 Virbac Latest Developments
13.6 Ceva
13.6.1 Ceva Company Information
13.6.2 Ceva Antiparasitic Drugs for Pets Product Portfolios and Specifications
13.6.3 Ceva Antiparasitic Drugs for Pets Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Ceva Main Business Overview
13.6.5 Ceva Latest Developments
13.7 Vetoquinol
13.7.1 Vetoquinol Company Information
13.7.2 Vetoquinol Antiparasitic Drugs for Pets Product Portfolios and Specifications
13.7.3 Vetoquinol Antiparasitic Drugs for Pets Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Vetoquinol Main Business Overview
13.7.5 Vetoquinol Latest Developments
13.8 Ouro Fino Saude
13.8.1 Ouro Fino Saude Company Information
13.8.2 Ouro Fino Saude Antiparasitic Drugs for Pets Product Portfolios and Specifications
13.8.3 Ouro Fino Saude Antiparasitic Drugs for Pets Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Ouro Fino Saude Main Business Overview
13.8.5 Ouro Fino Saude Latest Developments
13.9 JINDUN
13.9.1 JINDUN Company Information
13.9.2 JINDUN Antiparasitic Drugs for Pets Product Portfolios and Specifications
13.9.3 JINDUN Antiparasitic Drugs for Pets Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 JINDUN Main Business Overview
13.9.5 JINDUN Latest Developments
13.10 Zhongbolvya
13.10.1 Zhongbolvya Company Information
13.10.2 Zhongbolvya Antiparasitic Drugs for Pets Product Portfolios and Specifications
13.10.3 Zhongbolvya Antiparasitic Drugs for Pets Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Zhongbolvya Main Business Overview
13.10.5 Zhongbolvya Latest Developments
13.11 CAHIC
13.11.1 CAHIC Company Information
13.11.2 CAHIC Antiparasitic Drugs for Pets Product Portfolios and Specifications
13.11.3 CAHIC Antiparasitic Drugs for Pets Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 CAHIC Main Business Overview
13.11.5 CAHIC Latest Developments
14 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂